Evidence map›Paper›PMID 40673697›Full record

ArticleJournal of medical virology2025

Increase in HEV IgG Seroprevalence During the Past Years in Southern France.

Chloé Dimeglio, Mohamed El Rakaawi, Jérôme Boineau, Clémentine De Smet, Florence Abravanel, Sébastien Lhomme, Laurent Bardiaux, Jacques Izopet

Abstract read
In one paragraph

Article in Journal of medical virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chloé DimeglioLaboratory of Virology, National Reference Center on HEV, Institut Fédératif de Biologie, Toulouse University Hospital, Toulouse, France.ORCID 0000-0002-3713-4913
Mohamed El RakaawiEtablissement Français Du Sang, Toulouse, France.
Jérôme BoineauLaboratory of Virology, National Reference Center on HEV, Institut Fédératif de Biologie, Toulouse University Hospital, Toulouse, France.
Clémentine De SmetLaboratory of Virology, National Reference Center on HEV, Institut Fédératif de Biologie, Toulouse University Hospital, Toulouse, France.
Florence AbravanelLaboratory of Virology, National Reference Center on HEV, Institut Fédératif de Biologie, Toulouse University Hospital, Toulouse, France.ORCID 0000-0002-1753-1065
Sébastien LhommeLaboratory of Virology, National Reference Center on HEV, Institut Fédératif de Biologie, Toulouse University Hospital, Toulouse, France.ORCID 0000-0001-7908-1576
Laurent BardiauxEtablissement Français Du Sang, Toulouse, France.
Jacques IzopetLaboratory of Virology, National Reference Center on HEV, Institut Fédératif de Biologie, Toulouse University Hospital, Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sources and routes of HEV infections in industrialized countries are not fully defined. Occitanie in Southern France is an hyperendemic area but the relative extent of contaminated food and water consumption is unknown. We used validated assays to determine IgG and IgM seroprevalence among 3480 French blood donors living in Occitanie and compared the data with those obtained about twelve years ago. Epidemiological information was collected using a specific questionnaire. HEV IgG seroprevalence increased from 39.1% in 2011% to 47.8% in 2023. Unlike 12 years ago, the wastewater treatment method and tap water consumption were linked to HEV infection. Consumption of bottled water is now a risk factor for HEV infection. Overall IgM seroprevalence was 1.3%. The high prevalence of anti-HEV IgG in Occitanie cannot be explained by eating habits alone. Water consumption and treatment also appear to be important factors of HEV infections in Southern France.

Indexed as

Hepatitis AntibodiesHepatitis EHepatitis E virusImmunoglobulin GAdolescentAdultAgedBlood DonorsFemaleFranceHumansImmunoglobulin MMaleMiddle AgedRisk FactorsSeroepidemiologic StudiesHepatitis AntibodiesImmunoglobulin GImmunoglobulin MepidemiologyHEVrisk factorsseroprevalencewater

Identifiers

PMID40673697
PMCPMC12269536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.